NPPA recalculates Ceiling Price of Atorvastatin 10mg

The National Pharmaceutical Pricing Authority (NPPA) has recently adjusted the ceiling price for Atorvastatin 10mg tablets.

96
NPPA DPCO
NPPA

Last Updated on December 2, 2024 by The Health Master

NPPA

National Pharmaceutical Pricing Authority (NPPA) recalculates and revises ceiling price of atorvastatin 10 mg based on review order.

Key Highlights:

  • NPPA revises the ceiling price of Atorvastatin 10mg following a review order.
  • The new price is Rs. 4.97 per tablet, slightly higher than the previous one.
  • The revision is based on data from July 2022 and considers recent price changes.
  • The decision comes after a review application filed by Abbott Healthcare.

Understanding the Price Revision

The NPPA has recently adjusted the ceiling price for Atorvastatin 10mg tablets.

This decision stems from a review order issued by the Department of Pharmaceuticals (DoP) in October 2023.

The revised ceiling price, effective immediately, is set at Rs. 4.97 per tablet.

Why the Price Change?

The primary reason for the price revision is the consideration of updated data from July 2022. This data reflects recent changes in the market, including revised Price to Retailer (PTR) values for certain brands of Atorvastatin 10mg.

Abbott Healthcare’s Role

Drug major Abbott Healthcare filed a review application, highlighting that the NPPA had not considered the revised PTRs for brands like Atchol, Avas, and Lipikind while determining the initial ceiling price.

NPPA’s Response

The NPPA, in response to the review application, has acknowledged the delay in considering the revised PTRs.

However, the authority emphasized that the necessary forms for price revision were submitted after the deadline for representations against the draft ceiling price.

Impact on Patients and the Pharmaceutical Industry

The slight increase in the ceiling price of Atorvastatin 10mg is likely to have a minimal impact on patients, especially considering the overall affordability of the drug.

However, this decision underscores the importance of timely submission of relevant information to regulatory authorities for accurate price calculations.

By understanding the factors that led to the price revision, patients and healthcare providers can make informed decisions about medication choices.

  1. What is Atorvastatin 10mg?

    Atorvastatin 10mg is a generic medication used to lower cholesterol levels in the blood.

  2. Why did the NPPA revise the ceiling price?

    The NPPA revised the price based on updated data that reflected recent changes in the market, particularly the revised PTRs of certain brands.

  3. How will this affect patients?

    The impact on patients is expected to be minimal, as the increase in price is relatively small.

Disclaimer: This article contains information derived from the source mentioned below. Our team utilized an AI language model to rewrite and present the news or article in a unique format.

Disclaimer: This content, provides generic information only. It is in no way a substitute for a qualified medical opinion. Always consult a specialist or your own doctor for more information. The Health Master does not claim responsibility for this information.

For informative videos by The Health Master, click on the below YouTube icon:

YouTube Icon

For informative videos on Medical Store / Pharmacy, click on the below YouTube icon:

YouTube Icon

For informative videos on the news regarding Pharma / Medical Devices / Cosmetics / Homoeopathy etc., click on the below YouTube icon:

YouTube Icon

For informative videos on consumer awareness, click on the below YouTube icon:

YouTube Icon
Telegram
WhatsApp
Facebook
LinkedIn
YouTube Icon
Google-news